Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent

Previous studies have demonstrated that hydrogen sulfide (H(2)S) protects against multiple cardiovascular disease states in a similar manner as nitric oxide (NO). H(2)S therapy also has been shown to augment NO bioavailability and signaling. The purpose of this study was to investigate the impact of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: King, Adrienne L., Polhemus, David J., Bhushan, Shashi, Otsuka, Hiroyuki, Kondo, Kazuhisa, Nicholson, Chad K., Bradley, Jessica M., Islam, Kazi N., Calvert, John W., Tao, Ya-Xiong, Dugas, Tammy R., Kelley, Eric E., Elrod, John W., Huang, Paul L., Wang, Rui, Lefer, David J.
Format: Artigo
Langue:Inglês
Publié: National Academy of Sciences 2014
Sujets:
Biological Sciences
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3939925/
https://ncbi.nlm.nih.gov/pubmed/24516168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1321871111
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires